Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
N/A
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2006-12-15
Product name
Maxequin(R)
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
GHS Information
Signal word
DANGER
Section 2
SECTION 2: Hazards identification
Appearance: White Tablets
Signal word
DANGER
Hazard statements
Harmful if swallowed. May damage the unborn child. Toxic to aquatic life with long lasting effects.
Additional information
Short Term: Photosensitivity may occur. Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on blood, gastrointestinal system, liver, kidneys. Known Clinical Effects: Clinical use of this drug has caused photosensitivity, skin rash, nausea, diarrhea, abdominal pain, tongue discoloration, headache, seizure. EU Indication of danger: Harmful Toxic to Reproduction: Category 2 Dangerous for the Environment EU Hazard Symbols: EU Risk Phrases: R22 - Harmful if swallowed. R61 - May cause harm to the unborn child. R51/53 - Toxic to aquatic organisms. May cause long-term adverse effects in the aquatic environment. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
